Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of Z-207 in Seasonal Allergic Rhinitis
jRCT2080221241Phase 2
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of incobotulinumtoxinA in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Zeria Pharmaceutical Co., Ltd.
02
Drugs
incobotulinumtoxinA
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCT2080221241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221241.